Back to Search Start Over

COVID-19 tijdens zwangerschap en borstvoeding: wat weten we al?

Authors :
Ceulemans, Michael
Cuppers, B. (Benedikte)
de Vries, L. (Loes)
Allegaert, K.
Duvekot, J. J. (Hans)
van Puijenbroek, E. P.
Pharmacy
Obstetrics & Gynecology
Source :
Nederlands Tijdschrift voor Geneeskunde, 164(28):D5036. Bohn Stafleu van Loghum
Publication Year :
2020
Publisher :
Bohn Stafleu van Loghum BV, 2020.

Abstract

SARS-CoV-2 has rapidly spread worldwide since December 2019. Obviously, pregnant and lactating women will also be infected with SARS-CoV-2. Pregnant women, however, are a risk population for developing severe respiratory infections. Currently, the knowledge on potential risks and consequences of COVID-19 during pregnancy and lactation is limited. Available data show that pregnant women suffer from similar symptoms compared to non-pregnant patients. There is no evidence as yet that COVID-19 has a more serious course during pregnancy. Although pregnant women might suffer from a wide variety of symptoms, most of them are asymptomatic. Maternal SARS-CoV-2 infection might lead to adverse neonatal outcomes, such as prematurity or respiratory symptoms. There is currently no conclusive evidence of absence of intrauterine transmission of the virus; the virus has not been detected in breastmilk in most studies, although passage into breastmilk cannot be completely excluded. ispartof: Nederlands Tijdschrift voor Geneeskunde vol:164 ispartof: location:Netherlands status: published

Details

ISSN :
00282162
Database :
OpenAIRE
Journal :
Nederlands Tijdschrift voor Geneeskunde, 164(28):D5036. Bohn Stafleu van Loghum
Accession number :
edsair.dedup.wf.001..7f8427434087de799ffa6ec5c0cd4f38